123 related articles for article (PubMed ID: 37320881)
1. The added value of apparent diffusion coefficient and microcalcifications to the Kaiser score in the evaluation of BI-RADS 4 lesions.
Pan J; Huang X; Yang S; Ouyang F; Ouyang L; Wang L; Chen M; Zhou L; Du Y; Chen X; Deng L; Hu Q; Guo B
Eur J Radiol; 2023 Aug; 165():110920. PubMed ID: 37320881
[TBL] [Abstract][Full Text] [Related]
2. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
[TBL] [Abstract][Full Text] [Related]
3. Can DWI provide additional value to Kaiser score in evaluation of breast lesions.
An Y; Mao G; Ao W; Mao F; Zhang H; Cheng Y; Yang G
Eur Radiol; 2022 Sep; 32(9):5964-5973. PubMed ID: 35357535
[TBL] [Abstract][Full Text] [Related]
4. Improved Differential Diagnosis Based on BI-RADS Descriptors and Apparent Diffusion Coefficient for Breast Lesions: A Multiparametric MRI Analysis as Compared to Kaiser Score.
Meng L; Zhao X; Guo J; Lu L; Cheng M; Xing Q; Shang H; Zhang B; Chen Y; Zhang P; Zhang X
Acad Radiol; 2023 Sep; 30 Suppl 2():S93-S103. PubMed ID: 37236897
[TBL] [Abstract][Full Text] [Related]
5. Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.
Rong X; Kang Y; Xue J; Han P; Li Z; Yang G; Shi G
Eur Radiol; 2022 Nov; 32(11):7439-7447. PubMed ID: 35639141
[TBL] [Abstract][Full Text] [Related]
6. A Multicentric Comparison of Apparent Diffusion Coefficient Mapping and the Kaiser Score in the Assessment of Breast Lesions.
Dietzel M; Krug B; Clauser P; Burke C; Hellmich M; Maintz D; Uder M; Bickel H; Helbich T; Baltzer PAT
Invest Radiol; 2021 May; 56(5):274-282. PubMed ID: 33122603
[TBL] [Abstract][Full Text] [Related]
7. Assessment of breast lesions by the Kaiser score for differential diagnosis on MRI: the added value of ADC and machine learning modeling.
Chen ZW; Zhao YF; Liu HR; Zhou JJ; Miao HW; Ye SX; He Y; Liu XM; Su MY; Wang MH
Eur Radiol; 2022 Oct; 32(10):6608-6618. PubMed ID: 35726099
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of the Kaiser score in the evaluation of breast lesions on contrast-enhanced mammography.
Kang Y; Li Z; Yang G; Xue J; Zhang L; Rong X
Eur J Radiol; 2022 Nov; 156():110524. PubMed ID: 36126352
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Assessment of MR BI-RADS 4 Breast Lesions With Kaiser Score and Apparent Diffusion Coefficient Value.
Meng L; Zhao X; Lu L; Xing Q; Wang K; Guo Y; Shang H; Chen Y; Huang M; Sun Y; Zhang X
Front Oncol; 2021; 11():779642. PubMed ID: 34926290
[TBL] [Abstract][Full Text] [Related]
11. Incorporating diffusion-weighted imaging in a diagnostic algorithm for multiparametric MR mammography.
Vassiou K; Fanariotis M; Tsougos I; Fezoulidis I
Acta Radiol; 2022 Oct; 63(10):1332-1343. PubMed ID: 34605311
[TBL] [Abstract][Full Text] [Related]
12. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
[TBL] [Abstract][Full Text] [Related]
13. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
[TBL] [Abstract][Full Text] [Related]
14. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.
Li S; Lin Y; Liu G; Shao Z; Yang Y
Breast Cancer Res Treat; 2024 Jul; 206(2):425-435. PubMed ID: 38664289
[TBL] [Abstract][Full Text] [Related]
16. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
[TBL] [Abstract][Full Text] [Related]
17. Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.
Liu D; Ba Z; Ni X; Wang L; Yu D; Ma X
Med Sci Monit; 2018 Apr; 24():2180-2188. PubMed ID: 29644993
[TBL] [Abstract][Full Text] [Related]
18. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
[TBL] [Abstract][Full Text] [Related]
19. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity.
Arponen O; Masarwah A; Sutela A; Taina M; Könönen M; Sironen R; Hakumäki J; Vanninen R; Sudah M
Eur Radiol; 2016 Dec; 26(12):4361-4370. PubMed ID: 27114285
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy.
Clauser P; Krug B; Bickel H; Dietzel M; Pinker K; Neuhaus VF; Marino MA; Moschetta M; Troiano N; Helbich TH; Baltzer PAT
Clin Cancer Res; 2021 Apr; 27(7):1941-1948. PubMed ID: 33446565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
